CLINICAL_TRIALS
research
· 2017-07-02
Clinical Trial Update: Exposure to Neurotoxins as Risk Factors for Amyotrophic Lateral Sclerosis
Summary
A completed clinical trial investigates whether exposure to environmental neurotoxins is a risk factor for amyotrophic lateral sclerosis (ALS).
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: National Institute of Environmental Health Sciences (NIEHS) | Conditions: Amyotrophic Lateral Sclerosis, ALS | Status: COMPLETED